Next Article in Journal
Bronchopulmonary Dysplasia: Chronic Lung Disease of Infancy and Long-Term Pulmonary Outcomes
Next Article in Special Issue
Mammary Gland Involution Provides a Unique Model to Study the TGF-β Cancer Paradox
Previous Article in Journal
Combined Effects of Androgen and Growth Hormone on Osteoblast Marker Expression in Mouse C2C12 and MC3T3-E1 Cells Induced by Bone Morphogenetic Protein
Previous Article in Special Issue
The TGF-β/Smad4 Signaling Pathway in Pancreatic Carcinogenesis and Its Clinical Significance
Open AccessFeature PaperReview

Stromal Modulators of TGF-β in Cancer

1
Metastasis Research Laboratory, GIGA-Cancer, University of Liege, 4000 Liege, Belgium
2
Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Université Montpellier, Institut Régional du Cancer de Montpellier, 34298 Montpellier, France
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Emanuel F. Petricoin
J. Clin. Med. 2017, 6(1), 7; https://doi.org/10.3390/jcm6010007
Received: 4 November 2016 / Revised: 19 December 2016 / Accepted: 23 December 2016 / Published: 6 January 2017
(This article belongs to the Special Issue Biological and Clinical Aspects of TGF-beta in Carcinogenesis)
Transforming growth factor-β (TGF-β) is an intriguing cytokine exhibiting dual activities in malignant disease. It is an important mediator of cancer invasion, metastasis and angiogenesis, on the one hand, while it exhibits anti-tumor functions on the other hand. Elucidating the precise role of TGF-β in malignant development and progression requires a better understanding of the molecular mechanisms involved in its tumor suppressor to tumor promoter switch. One important aspect of TGF-β function is its interaction with proteins within the tumor microenvironment. Several stromal proteins have the natural ability to interact and modulate TGF-β function. Understanding the complex interplay between the TGF-β signaling network and these stromal proteins may provide greater insight into the development of novel therapeutic strategies that target the TGF-β axis. The present review highlights our present understanding of how stroma modulates TGF-β activity in human cancers. View Full-Text
Keywords: cancer-associated fibroblasts; proteases; proteoglycans; TGF-β; stroma cancer-associated fibroblasts; proteases; proteoglycans; TGF-β; stroma
Show Figures

Figure 1

MDPI and ACS Style

Costanza, B.; Umelo, I.A.; Bellier, J.; Castronovo, V.; Turtoi, A. Stromal Modulators of TGF-β in Cancer. J. Clin. Med. 2017, 6, 7.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop